These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4586952)

  • 1. Clinical experience with a new anticancer agent, carbazilquinone (NSC-134679).
    Saito T; Oira S; Wakui A; Yokoyama M; Takahashi H
    Cancer Chemother Rep; 1973; 57(4):447-57. PubMed ID: 4586952
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with a new anticancer agent, carbazilquinone].
    Saito T; Oira S; Wakui A; Yokoyama M; Takahashi H
    Gan No Rinsho; 1971 Nov; 17(11):806-18. PubMed ID: 4947602
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of malignant cancer using carbazilquinone].
    Kurita S; Nishimura M; Ogawa M; Kamei Y; Imai K
    Gan No Rinsho; 1971 Oct; 17(10):744-9. PubMed ID: 5166829
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical studies on carbazilquinone in the treatment of malignant diseases].
    Kurita S; Nishimura M; Ogawa M; Kamei Y; Ariyoshi Y
    Nihon Gan Chiryo Gakkai Shi; 1973 Jun; 8(2):119-27. PubMed ID: 4738331
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210.
    Straus MJ; Goldin A
    Cancer Chemother Rep; 1972 Feb; 56(1):19-23. PubMed ID: 5030804
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):667-73. PubMed ID: 4895430
    [No Abstract]   [Full Text] [Related]  

  • 7. Complete inhibition of mouse lymphoid leukemia L-1210 by carbazilquinone.
    Arakawa M
    Gan; 1972 Aug; 63(4):487-9. PubMed ID: 5081624
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional perfusion and circulation-stop method for chemotherapy of cancer and metastasis.
    Baba T; Kimura NT; Kanematsu T; Aoki K
    Gan; 1974 Jun; 65(3):285-7. PubMed ID: 4854067
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of carbazilquinone on leukemic cell count in various tissues of mice bearing leukemia L-1210.
    Arakawa M; Okada N
    Gan; 1974 Feb; 65(1):21-5. PubMed ID: 4825388
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of carbazilquinone on lymphoid leukemia L-1210.
    Arakawa M; Aoki T; Nakao H
    Gan; 1970 Oct; 61(5):485-93. PubMed ID: 5476838
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of the clinical study of a preparation of diiodobenzotef in malignant tumors].
    Karev NI; Garin AM; Blokhina NG; Pershin MP; Trapeznikova MF
    Klin Med (Mosk); 1975 May; 52(5):50-3. PubMed ID: 1133992
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of anticancer alkylating agent, carboquone (NSG-134679).
    Himori T; Wakui A; Saito T
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):92-9. PubMed ID: 6678502
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy of malignant tumors. 44].
    Seidenglanz G
    Pharm Prax; 1970; 6():122-38. PubMed ID: 4917035
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anticancer chemotherapy with evaluation of combined treatments].
    Saito T
    Poumon Coeur; 1968; 24(1):129-31. PubMed ID: 5652199
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of chemotherapy with dual antagonists and radiotherapy in the treatment of neoplastic disease.
    Bardos TJ; Ambrus JL; Ambrus CM
    J Surg Oncol; 1971; 3(4):431-41. PubMed ID: 5097626
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase I study of SOAz.
    Nasca S; Jezekova D; Coninx P; Garbe E; Carpentier Y; Cattan A
    Cancer Treat Rep; 1982 Dec; 66(12):2039-42. PubMed ID: 7139646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential bioreductive alkylating agents. 3. Synthesis and antineoplastic activity of acetoxymethyl and corresponding ethyl carbamate derivatives of benzoquinones.
    Lin AJ; Shansky CW; Sartorelli AC
    J Med Chem; 1974 May; 17(5):558-61. PubMed ID: 4830263
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I study of ethylbis(2,2-dimethyl-1-aziridinyl) phosphinate (AB-163).
    Wampler GL; Kuperminc M; Regelson W
    Cancer Chemother Pharmacol; 1980; 4(1):49-52. PubMed ID: 7363402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dosage schedule of new anticancer drugs--evaluation of the use of 3 anticancer drugs in the study of phases 1 and 2].
    Saito T; Oira S; Wakui A; Yokoyama M; Himori T
    Gan No Rinsho; 1971 Aug; 17(8):589-98. PubMed ID: 4328514
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacology of isophosphamide.
    Creaven PJ; Allen LM; Alford DA; Cohen MH
    Clin Pharmacol Ther; 1974 Jul; 16(1):77-86. PubMed ID: 4602057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.